Kenfarb & Co’s Pfizer PFE Stock Holding History

Kenfarb & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$388K	Hold	11,700	–	–	0.35%	70
2023 Q2	$429K	Hold	11,700	–	–	0.37%	70
2023 Q1	$477K	Hold	11,700	–	–	0.43%	62
2022 Q4	$600K	Hold	11,700	–	–	0.53%	57
2022 Q3	$512K	Buy	11,700 +200	+2%	+$9.72K	0.49%	56
2022 Q2	$595K	Hold	11,500	–	–	0.47%	58
2022 Q1	$595K	Hold	11,500	–	–	0.47%	58
2021 Q4	$679K	Buy	+11,500	New	+$570K	0.5%	52

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kenfarb & Co's PFE Position: Q3 2023 in Review

Kenfarb & Co held its Pfizer (PFE) position steady in Q3 2023 at 11,700 shares worth $388K. The position accounts for 0.35% of the portfolio, ranked #70.

Kenfarb & Co first reported a position in PFE in Q4 2021 and has held it in 8 quarters since. The position peaked at $679K in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Kenfarb & Co held 11,700 shares of Pfizer worth $388K as of Q3 2023.
Kenfarb & Co left its Pfizer share count unchanged in Q3 2023.
Pfizer made up 0.35% of Kenfarb & Co's portfolio in Q3 2023, its #70 holding.
Kenfarb & Co first reported a position in Pfizer in Q4 2021 and has held it in 8 quarters since.
Kenfarb & Co's Pfizer position peaked at $679K in Q4 2021.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Kenfarb & Co's 13F filing for Q3 2023, filed 14 Nov 2023.